Immunohistochemical Localization of Wild-type EGFR, E746-A750 Frame Deletion in Exon 19, and L858R Point Mutation in Exon 21 in Triple-negative Breast Cancer

Applied Immunohistochemistry & Molecular Morphology : AIMM
Hemangini H VoraShilin N Shukla

Abstract

This study evaluated wild-type EGFR, E746-A750 frame deletion in exon 19, and L858R point mutation in exon 21 by immunohistochemistry in patients with triple-negative breast cancer (TNBC). A retrospective study included 99 untreated early-stage and advanced-stage TNBC patients. Immunohistochemical localization of wild-type EGFR, EGFR E746-A750 deletion in exon 19, and EGFR L858R mutation in exon 21 was performed on formalin-fixed paraffin-embedded tissue blocks using mutation-specific primary antibodies. EGFR protein expression was noted in 27% (27/99) of patients with 2+ or 3+ staining intensity in 7% (7/99) of patients. Significant correlation of EGFR protein expression with subgroups of clinicopathologic parameters was not found. In univariate and multivariate survival analysis, high EGFR expression (2+ or 3+) emerged as a significant prognostic factor for disease-free survival. With respect to mutation status, exon 19 deletion was observed in 3% (3/99) of patients. One patient with exon 19 deletion having high EGFR protein (2+) expression developed lung metastasis, whereas the other 2 patients with exon 19 deletion had low EGFR protein (1+) expression and remained disease free during the study period. EGFR protein overexpre...Continue Reading

References

Aug 30, 2000·Nature·C M PerouD Botstein
May 28, 2005·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Rohit BhargavaBeiyun Chen
Jun 2, 2006·The Journal of Pathology·J S Reis-FilhoF C Schmitt
Jan 16, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D GeneraliA L Harris
Apr 16, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jian YuMichael J Comb
Jun 24, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Atsuko KitamuraYasushi Yatabe
Feb 2, 2012·Diagnostic Pathology·Pierre-Jean Lamy, William Jacot
Mar 8, 2012·Journal of Receptor and Signal Transduction Research·Imen KallelAhmed Rebaï
Mar 21, 2012·Lancet·Priya Shetty
Apr 7, 2012·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Hiroki NakajimaTetsunari Oyama
May 23, 2012·Breast Cancer Research and Treatment·Tobias J GrobAnnette Lebeau
Sep 27, 2012·BMC Clinical Pathology·Shant Kishen Kanapathy PillaiChee-Onn Leong

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping

Software Mentioned

Sequenom
SPSS

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.